Eucrates Biomedical
Why Robinhood?
You can watch EUCR and buy or sell other stocks, ETFs, and their options commission-free!About EUCR
Eucrates Biomedical Acquisition Corp. operates as a blank Check company focusing on acquiring, engaging in a share exchange, share reconstruction and amalgamations. The company was founded by Stelios Papadopoulos, Parag Saxena, Evangelos Vergetis and Daphne Karydas on August 21, 2020 and is headquartered in New York, NY.
EUCR Key Statistics
Stock Snapshot
Eucrates Biomedical(EUCR) stock is priced at $10.04, giving the company a market capitalization of 42.23M. It carries a P/E multiple of 53.46.
On 2026-04-18, Eucrates Biomedical(EUCR) stock opened at —, reached a high of —, and a low of —.
Eucrates Biomedical(EUCR) shares are trading with a volume of 0, against a daily average of 7.18K.
In the last year, Eucrates Biomedical(EUCR) shares hit a 52-week high of $10.25 and a 52-week low of $9.87.
In the last year, Eucrates Biomedical(EUCR) shares hit a 52-week high of $10.25 and a 52-week low of $9.87.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.